Tissueblue 0.025% syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DX25F6XQZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,654
Award facts
- Contract value 100% obligated
- $1,654.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On August 18, 2025, the Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $1,654.44 to DMS Pharmaceutical Group Inc. for TISSUEBLUE 0.025% Syringe 0.5ML. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge location. The company holds a significant single-award Indefinite Delivery Contract with the DLA under the SPE2DB program valued at $499,999,999 and valid through November 2026, which serves as the vehicle enabling the agency to issue firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards demonstrating expertise in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's consistent success in securing federal contracts without set-aside designations reflects its competitive positioning as a woman-owned small business in the pharmaceutical distribution market. This delivery order for TISSUEBLUE represents a routine procurement under the company's established IDC vehicle, contributing to the comprehensive pharmaceutical support provided to military healthcare operations.
Quick answers
Who was awarded contract SPE2DX25F6XQZ?
SPE2DX25F6XQZ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 18, 2025.
How much is contract SPE2DX25F6XQZ worth?
The government has obligated $1,654 on SPE2DX25F6XQZ.
Is contract SPE2DX25F6XQZ an order under another contract?
Yes. SPE2DX25F6XQZ is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XQZ competed?
The extent of competition for SPE2DX25F6XQZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award